Identification of Potential Drug Targets for Generalized Anxiety Disorder: A Mendelian Randomization Study Based on Druggable Genes
This study suggested that the KDM5A gene might be a potential therapeutic target for treating GAD, providing a direction for future drug development in GAD patients.
Authors
- Shijia Fan (ORCID: https://orcid.org/0000-0002-7400-9492)
- Ande Bao (ORCID: https://orcid.org/0009-0007-0096-2858)
- Jingui Wang (ORCID: https://orcid.org/0000-0001-9947-9821)
- Hai-Ning Zhang (ORCID: https://orcid.org/0000-0002-4573-6746)
- Hongyi Wang (ORCID: https://orcid.org/0000-0002-1076-1140)
- Jiacheng Zhang (ORCID: https://orcid.org/0000-0002-9027-6531)
- Huanan Li (ORCID: https://orcid.org/0000-0003-1727-2937)
- Yusheng Li (ORCID: https://orcid.org/0009-0006-7414-9053)
Institutions
- State Administration of Traditional Chinese Medicine of the People's Republic of China (CN)
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Current Pharmaceutical Biotechnology
- Published
- 2025-10-28
- DOI
- https://doi.org/10.2174/0113892010393317251014080710
- Citations
- 1
- Primary Topic
- Genetic Associations and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.82